INS and diabetes mellitus: These include reduced HbA1c,15, 16, 17 reduced total daily dose (TDD) of insulin,18, 19 weight loss,19 reduced hospital admissions for DKA or severe hypoglycaemia,20, 21 improvements in treatment satisfaction and self‐reported diabetes‐related behaviours.19